Correlation Between Sabra Health and Q2M Managementberatu
Can any of the company-specific risk be diversified away by investing in both Sabra Health and Q2M Managementberatu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabra Health and Q2M Managementberatu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabra Health Care and Q2M Managementberatung AG, you can compare the effects of market volatilities on Sabra Health and Q2M Managementberatu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabra Health with a short position of Q2M Managementberatu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabra Health and Q2M Managementberatu.
Diversification Opportunities for Sabra Health and Q2M Managementberatu
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Sabra and Q2M is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Health Care and Q2M Managementberatung AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Q2M Managementberatung and Sabra Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabra Health Care are associated (or correlated) with Q2M Managementberatu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Q2M Managementberatung has no effect on the direction of Sabra Health i.e., Sabra Health and Q2M Managementberatu go up and down completely randomly.
Pair Corralation between Sabra Health and Q2M Managementberatu
Assuming the 90 days horizon Sabra Health Care is expected to generate 4.52 times more return on investment than Q2M Managementberatu. However, Sabra Health is 4.52 times more volatile than Q2M Managementberatung AG. It trades about 0.06 of its potential returns per unit of risk. Q2M Managementberatung AG is currently generating about -0.19 per unit of risk. If you would invest 1,502 in Sabra Health Care on October 3, 2024 and sell it today you would earn a total of 109.00 from holding Sabra Health Care or generate 7.26% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sabra Health Care vs. Q2M Managementberatung AG
Performance |
Timeline |
Sabra Health Care |
Q2M Managementberatung |
Sabra Health and Q2M Managementberatu Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sabra Health and Q2M Managementberatu
The main advantage of trading using opposite Sabra Health and Q2M Managementberatu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabra Health position performs unexpectedly, Q2M Managementberatu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Q2M Managementberatu will offset losses from the drop in Q2M Managementberatu's long position.Sabra Health vs. Superior Plus Corp | Sabra Health vs. NMI Holdings | Sabra Health vs. Origin Agritech | Sabra Health vs. SIVERS SEMICONDUCTORS AB |
Q2M Managementberatu vs. Novo Nordisk AS | Q2M Managementberatu vs. CSL Limited | Q2M Managementberatu vs. Mercedes Benz Group AG | Q2M Managementberatu vs. NMI Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |